MedTrace Logo

Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)

NCT06096324 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2026-03-04

No results posted yet for this study

Summary

The study team will conduct a two-group study to examine the efficacy of implementing a combination intervention to improve economic stability and HIV preventive behaviors. The team will enroll approximately 500 young adults. Participants will be randomly assigned to one of two groups. The first group ("control") will receive text messages with information on job openings. The second group ("intervention") will receive text messages with information on job openings plus HIV prevention text messages, educational sessions on employment, income generation, and HIV prevention, economic resources, and mentoring.

Conditions

  • Economic Hardship
  • Condomless Sex
  • Utilization, Health Care

Interventions

BEHAVIORAL

Job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring.

Participants will receive job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring.

BEHAVIORAL

Job announcements

Participants will receive job announcements only.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Larissa Jennings Mayo-Wilson, PhD MHS · University of North Carolina, Chapel Hill

  • Adriana Parker, MPH · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-19
Primary Completion
2028-03-31
Completion
2028-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06096324 on ClinicalTrials.gov